NAD Research Investments and the Critical Role of Pharmacists in Supplement Education and Policy Reform

In this Pharmacy Times interview, Andrew Shao, PhD, senior vice president for global regulatory and scientific affairs at Niagen Bioscience, discusses the company’s extensive investment in scientific research supporting nicotinamide adenine dinucleotide (NAD)–related products, including dozens of patents and clinical trials. He highlights efforts to improve transparency and consumer education through third-party certifications, published research, and educational platforms such as AboutNAD.com. Shao also emphasizes the pivotal role pharmacists play as trusted, accessible sources of information for patients navigating supplement use. Because many physicians receive limited nutrition training, he notes that pharmacists are uniquely positioned to guide consumers toward evidence-based products and away from misleading marketing.